Milne Institute Current Research

  • 50 Gaylord Farm Road
    Wallingford, CT 06492
  • (203) 284-2800
  • (203) 284-2700 (TTY/TDD)
Video Tour

Discover how Gaylord's setting provides a restorative, healing environment for our patients and their families. For details and videos about specific programs see the individual program pages.

Current Research

Click the links for research details. 

This outpatient study will trial the effects of using Blood Flow Restriction during physical therapy sessions for Patellofemoral Pain Syndrome. It will determine if adding this to traditional physical therapy improves recovery time and if it affects pain levels.

This trial is designed to test whether treatment of obstructive sleep apnea (OSA) with continuous positive airway pressure is effective for secondary prevention and recovery after stroke. Gaylord Hospital is a partner site in this study.

The purpose of this study is to evaluate Sound Level Meter (SLM) measurements as a new metric for the decannulation protocol and predictor of decannulation success at our facility.

The purpose of this study is to compare outcomes in individuals with Medicare who qualify for LTACH admission under the 3 midnight stay in ICU rule, to those who were previously non-qualified, but were allowed admission to our LTACH as a result of the CARES Act to determine if differences exist between the groups.

This multiphase study will try to validate a new cognitive screen for our Occupational Therapy department that measures cognitive function in patients admitted to Gaylord Hospital in order to help shape a more informed treatment plan.

The goal of this multisite study is to determine what effect the novel Training Responses in Postural Rehabilitation (TRiP) balance perturbation module for the ZeroG body-weight support system has on rehabilitating patients’ balance control following an acute stroke. Collaborating sites: MedStar National Rehabilitation Hospital, Washington, DC; Providence St. Luke’s Rehabilitation Medical Center, Spokane, WA; Spaulding Rehabilitation Hospital Cape Cod, Sandwich, MA. NCT05110300

A retrospective review that will describe characteristics of people with acute Guillain-Barre Syndrome treated in a long term acute care setting.

The purpose of this study is to determine if the use of the Passy-Muir Valve improves endurance for patients in long term acute care setting as measured with the Six Minute Walk Test in therapy sessions over the course of three weeks. NCT04941456

This study is a randomized, double-blinded, phase III clinical trial designed to test the efficacy and safety of anticoagulation, compared with aspirin, in patients with a recent ICH and high-risk non-valvular atrial fibrillation/flutter (AF).

An online survey designed to explore the opinions and acceptability of anterior cruciate ligament reconstruction surgical stakeholders, including Physical Therapists on the integration of tele-rehabilitation into early phase post-operative rehabilitation.

This study aims at determining the effectiveness of peak expiratory flow measurements in influencing the decision to decannulate.

A prospective observational cohort study that will provide at-risk patients with undisrupted observation hoping to reduce the number and rate of inpatient falls and will reduce some of the financial burden associated with 1:1 Sitters.

This is a multisite study led by University of California San Francisco in which Gaylord Hospital is a major contributor. Partnering with NALTH, RAFT is conducting a series of observational studies to examine the clinical course of older adults with SARS-Cov-2 (COVID-19) using federally-mandated patient assessment data on LTACH admission and discharge (inpatients), augmented with interviews 6 and 12 months after hospital admission

To determine the effects of continuation vs. discontinuation of statins on the risk of ICH recurrence during 24 months of follow-up in patients presenting with a spontaneous lobar lCH while taking a statin drug.

A randomized control trial on patients diagnosed with acute neurological visual impairment. The aim of this study is to compare BITS touch screen technology with traditional tabletop activities and their effectiveness at improving visual field awareness. NCT04930822

A multicenter, randomized, double-blind, active-control study to compare the effects of apixaban versus aspirin in patients with unexplained ischemic stroke and atrial cardiopathy to see which is better at prevention of future strokes

A study to evaluate the natural history of a stroke using a low field MRI (Hyperfine).  Stroke patients are scanned shortly after admission and then every 5-7 days until discharge to track the progression of a stoke using low field, portable MRI technology. This information is also compared to standard outcomes measures to determine how these correlate with the progression of the stroke seen in the MRI images.

Gaylord Specialty Healthcare is a partner in the Spaulding New England Regional Spinal Cord Injury Center (SNERSCIC). The overall goal of SNERSCIC is to provide a multidisciplinary comprehensive system of care for individuals with SCI as a basis for conducting research that extends the existing evidence base for SCI rehabilitation. Our focus is health, function and technology, especially for the most vulnerable, to empower individuals with SCI to lead fulfilling and meaningful lives.

As a partner site in the Model System, we conduct some SCI Model System studies:

The National Spinal Cord Injury Database Project

The purpose of this core study is to allow healthcare professionals and researchers to evaluate trends over time for many aspects of SCI to improve rehabilitation services and help people with SCI live the best they can in the community.  Data collection begins during the inpatient rehabilitation stay, is updated approximately one year after injury, and every five years thereafter.  No medical procedures are involved and information is gathered through a one-on-one interview by phone or in person.

If you believe you are enrolled in the study, please contact Diana Pernigotti at 203-679-3563 or for information regarding your follow up status or to update your contact information.

Contact Us